Barnett & Company’s Eli Lilly LLY Stock Holding History

Barnett & Company’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-20	Closed	-$6K	–	185
2021 Q4	$6K	Buy	+20	New	+$5.07K	﹤0.01%	221
2019 Q1	–	Sell	-280	Closed	-$32K	–	318
2018 Q4	$32K	Hold	280	–	–	0.02%	205
2018 Q3	$30K	Hold	280	–	–	0.01%	227
2018 Q2	$24K	Hold	280	–	–	0.01%	219
2018 Q1	$22K	Hold	280	–	–	0.01%	230
2017 Q4	$24K	Hold	280	–	–	0.01%	234
2017 Q3	$24K	Hold	280	–	–	0.01%	231
2017 Q2	$23K	Hold	280	–	–	0.01%	258
2017 Q1	$24K	Sell	280 -277	-50%	-$22.2K	0.01%	231
2016 Q4	$41K	Hold	557	–	–	0.02%	218
2016 Q3	$45K	Buy	557 +255	+84%	+$20.4K	0.02%	215
2016 Q2	$24K	Hold	302	–	–	0.01%	256
2016 Q1	$22K	Buy	+302	New	+$22.9K	0.01%	276

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Barnett & Company's LLY Position: Q1 2022 in Review

Barnett & Company sold out of Eli Lilly (LLY) in Q1 2022, closing a stake of 20 shares — an estimated $6K sold.

Barnett & Company first reported a position in LLY in Q1 2016 and held it in 13 quarters. The position peaked at $45K in Q3 2016. 2,345 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

Barnett & Company reported no remaining Eli Lilly position as of Q1 2022 after selling out during the quarter.
Barnett & Company sold 20 Eli Lilly shares in Q1 2022, an estimated $6K.
Barnett & Company first reported a position in Eli Lilly in Q1 2016 and held it in 13 quarters.
Barnett & Company's Eli Lilly position peaked at $45K in Q3 2016.
2,345 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on Barnett & Company's 13F filing for Q1 2022, filed 28 Apr 2022.